Abstract
Aims: Lung transplantation in patients with severe respiratory failure requires extracorporeal support. However, both cardio-pulmonary bypass and ECMO are associated with substantial side effects and risks. The pumpless interventional lung assist (Novalung®) may present a safe and effective alternative.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
